Similarly, NOD2 (CARD15) LOF polymorphisms are associated with an increased risk of clinical allergy and inflammatory bowel disease (IBD), whereas activating mutations cause the autoinflammatory disease Blau syndrome (Figure 2) (21, 118, 119). Here, NOD2 is linked to inflammatory bowel disease.